Press Releases Rafael Holdings, Inc.

Equities

RFL

US75062E1064

Market Closed - Nyse Other stock markets 04:00:02 2024-07-05 pm EDT			5-day change	1st Jan Change
1.45 ^USD	+1.40%		+0.69%	-20.77%

Jun. 14	Rafael Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2024	CI
Jun. 11	Cyclo Therapeutics, Inc. announced that it has received $2 million in funding from Rafael Holdings, Inc.	CI

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Rafael Holdings Reports Third Quarter Fiscal 2024 Financial Results	Jun. 14	GL
Cyclo Therapeutics Achieves Landmark Milestone with Completion of Enrollment of Last Patient in Phase 3 Pivotal TransportNPC™ Trial of Niemann-Pick Type C1	May. 30	BU
Rafael Holdings Reports Second Quarter Fiscal 2024 Financial Results	Mar. 13	GL
Rafael Holdings Reports First Quarter Fiscal 2024 Financial Results	Dec. 14	GL
Cyclo Therapeutics Reports Third Quarter 2023 Financial Results	Nov. 15	BU
Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2023 Financial Results	23-10-30	GL
Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2023 Financial Results	23-10-30	AQ
Cyclo Therapeutics Reports Second Quarter 2023 Financial Results	23-08-15	BU
Rafael : Changes in Control - Form 8-K	23-08-02	PU
Cyclo Therapeutics Announces Closing of $5.0 Million Private Placement with Rafael Holdings, Inc.	23-08-02	BU
Rafael Holdings Reports Third Quarter Fiscal 2023 Financial Results and Provides Business Update	23-06-13	GL
Rafael : On June 1, 2023, Rafael Holdings, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with Cyclo Therapeutics, Inc., a Nevada corporation (“Cyclo”). Pursuant to the Purchase Agreement, the Company will purchase 4,000,000 shares of common stock (the “Shares”), and a warrant to purchase an additional 4,000,000 Shares (the “Warrant”), for an aggregate purchase price of $5,000,000. The Warrant has an ex	23-06-05	PU
Cyclo Therapeutics Announces Execution of Definitive Agreement with Rafael Holdings, Inc. Providing for $5.0 Million of Additional Funding Via a Private Placement	23-06-05	BU
Cyclo Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results	23-05-15	BU
Cyclo Therapeutics Announces Closing of Strategic Investment Through a $2.1 Million Private Placement from Rafael Holdings, Inc. (NYSE:RFL)	23-05-02	BU
RAFAEL HOLDINGS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	23-04-04	AQ
Rafael Holdings Announces up to $5 Million Share Repurchase Program	23-04-04	GL
RAFAEL HOLDINGS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	23-03-14	AQ
RAFAEL HOLDINGS, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	23-03-14	AQ
Rafael Holdings Reports Second Quarter Fiscal 2023 Financial Results	23-03-14	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Rafael Holdings, Inc.

Equities

RFL

US75062E1064

Press Releases

Filters